1. Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes
- Author
-
Jun-Xu Gu, Juan Huang, Kun Wang, Yue Yin, Jun-Ling Fang, Ai-Min Zhang, Shan-Shan Li, Xiao-Qin Yao, Ming Yang, Na Zhang, Mei Jia, and Ming Su
- Subjects
Type 2 diabetes mellitus ,lipoprotein(a) ,Cardiovascular events ,Risk indicator ,Coronary heart disease ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: High circulatory lipoprotein(a) [Lp(a)] concentration promotes atherosclerosis; however, its efficacy in predicting the extent of atherosclerotic coronary heart disease (CHD) with coronary artery obstruction and major adverse cardiovascular events (MACEs) in diabetic patients remains questionable. This study aimed to examine whether elevated circulating Lp(a) levels exacerbate CHD and to assess their utility in predicting MACEs in individuals diagnosed with type 2 diabetes mellitus (T2DM). Methods: In total, 4332 patients diagnosed with T2DM who underwent coronary angiography (CAG) were included and categorized into two groups (CHD and non-CHD) based on the CAG results. We used a correlation analysis to explore the potential links between the levels of circulating Lp(a) and CHD severity. Cox regression analysis was performed to evaluate MACEs. Results: The concentrations of circulating Lp(a) were markedly elevated in the CHD group and positively correlated with disease severity. Our results indicate that elevated circulating Lp(a) is a crucial risk factor that significantly contributes to both the progression and severity of CHD. The differences between the two groups are evident in the risk of CHD occurrence [odds ratio (OR) = 1.597, 95 % confidence interval (CI): 1.354โ1.893, p
- Published
- 2024
- Full Text
- View/download PDF